Cell Culture Conditions for KSHV and EBV Studies
Corresponding Organization :
Other organizations : Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Second Affiliated Hospital of Nanjing Medical University, Eulji University, UPMC Hillman Cancer Center, Jiangsu Province Hospital, University of Florida, University of Southern California
Variable analysis
- KSHV-positive and EBV-negative PEL cell lines BC-3 and BCBL-1
- KSHV-negative and EBV-negative B lymphocyte lines DG75, Loukes and BJAB cells
- HEK293T cells
- EA.hy926 cells
- Primary human umbilical vein endothelial cells (HUVECs)
- Wild type recombinant KSHV BAC16
- KSHV mutant with miR-K3 deleted, BAC16ΔmiR-K3
- Not explicitly mentioned
- RPMI-1640 containing 10% heat-inactivated fetal bovine serum (FBS), 2 mmol/L of L-glutamine, 100 U/ml of penicillin, and 100 μg/mL of streptomycin at 37°C in a humidified, 5% CO2 atmosphere
- Dulbecco's modified Eagle's medium (DMEM) with 10% FBS
- Complete EBM-2 culture media (LONZA, Allendale, NJ, USA) for HUVECs
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!